Evenepoel Wins Stage 16 Time Trial as Doping Test Court Dispute Resolved

Remco Evenepoel won his second consecutive Tour de France stage while a Paris judge authorized controversial night-time doping tests on Pogacar and Vingegaard.

A Paris judge authorized overnight anti-doping tests on Tadej Pogacar and Jonas Vingegaard after the International Testing Agency sought legal clearance to test the two riders outside the standard 6am–11pm window ahead of stage 15. The ITA had petitioned the Paris prosecutor's office directly, signaling an unusual escalation in the effort to test the Tour's top general classification contenders during restricted hours. On the road, Remco Evenepoel delivered a dominant performance in the stage 16 time trial between Evian and Thonon-les-Bains, claiming back-to-back stage victories and trimming Pogacar's lead in the overall classification. The Belgian's consecutive wins mark him as the standout performer in the race's individual time trial stages. The night-time testing dispute has drawn significant attention to anti-doping protocols at the Tour, where athletes can normally only be tested between 6am and 11pm. The ITA's decision to seek a court order to extend that window specifically for the two leading contenders underscores the scrutiny on the race's top riders.

Why it matters

The court-authorized extension of doping test hours at the Tour de France sets a notable precedent for how anti-doping authorities can pursue testing outside standard windows for high-profile athletes. Evenepoel's stage wins also signal a shift in the competitive dynamics of the race.

What's next

It remains to be seen whether the authorized night-time tests were carried out and whether the results will be disclosed, and how Pogacar will respond to Evenepoel's encroachment on the overall standings.

Key facts

Bias & framing notes

Both sources are from The Guardian. The headline of Source 1 frames the doping test dispute as a deepening 'row,' lending a more dramatic tone, while Source 2 reports the court resolution more neutrally. Neither source provides the ITA's or riders' detailed statements on the night-time testing rationale, leaving the stated justification underreported.

NewsClear — neutral news & congressional tracking · Bill of the Week